P Segal

1.2k total citations
33 papers, 908 citations indexed

About

P Segal is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P Segal has authored 33 papers receiving a total of 908 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P Segal's work include Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cancer, Lipids, and Metabolism (5 papers). P Segal is often cited by papers focused on Lipoproteins and Cardiovascular Health (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Cancer, Lipids, and Metabolism (5 papers). P Segal collaborates with scholars based in Israel, United States and Germany. P Segal's co-authors include Paul S. Roheim, Meir Berezin, Michaela Modan, Ayala Lusky, Zvi Vered, Henry N. Neufeld, Alexander Battler, David A. Liberman, Hillel Halkin and Z Fuchs and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Journal of the American College of Cardiology.

In The Last Decade

P Segal

31 papers receiving 851 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Segal Israel 17 351 245 239 211 100 33 908
J D Morrisett United States 13 316 0.9× 440 1.8× 279 1.2× 154 0.7× 143 1.4× 18 928
Masaharu Kubo Japan 18 306 0.9× 346 1.4× 126 0.5× 212 1.0× 85 0.8× 46 803
Hulda J. Wohltmann United States 15 404 1.2× 215 0.9× 130 0.5× 148 0.7× 98 1.0× 30 767
J. Frohlich Canada 16 388 1.1× 538 2.2× 177 0.7× 185 0.9× 75 0.8× 33 887
A. Gustafson Sweden 18 399 1.1× 312 1.3× 120 0.5× 177 0.8× 88 0.9× 63 881
Ryoyu Takeda Japan 19 481 1.4× 414 1.7× 209 0.9× 186 0.9× 48 0.5× 57 973
James P. Corsetti United States 20 373 1.1× 460 1.9× 186 0.8× 234 1.1× 165 1.6× 49 1.1k
Yuan-Teh Lee Taiwan 15 96 0.3× 179 0.7× 296 1.2× 244 1.2× 58 0.6× 25 886
Tomáš Štulc Czechia 16 263 0.7× 567 2.3× 198 0.8× 258 1.2× 89 0.9× 58 1.0k
M van Linde-Sibenius Trip Netherlands 8 480 1.4× 706 2.9× 401 1.7× 116 0.5× 57 0.6× 8 1.2k

Countries citing papers authored by P Segal

Since Specialization
Citations

This map shows the geographic impact of P Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Segal more than expected).

Fields of papers citing papers by P Segal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Segal. The network helps show where P Segal may publish in the future.

Co-authorship network of co-authors of P Segal

This figure shows the co-authorship network connecting the top 25 collaborators of P Segal. A scholar is included among the top collaborators of P Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Segal. P Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Segal‐Lieberman, Gabriella, P Segal, & Dror Dicker. (2016). Revisiting the Role of BMI in the Guidelines for Bariatric Surgery. Diabetes Care. 39(Supplement_2). S268–S273. 14 indexed citations
2.
Segal, P, et al.. (2005). Long-Term Efficacy and Tolerability of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus. Clinical Drug Investigation. 25(9). 589–595. 12 indexed citations
3.
Segal, P. (2002). Postprandial dysmetabolism and large-vessel disease.. PubMed. 15(6 Suppl). 3–8. 2 indexed citations
4.
Gaal, L. Van, et al.. (2001). Miglitol combined with metformin improves glycaemic control in type 2 diabetes. Diabetes Obesity and Metabolism. 3(5). 326–331. 38 indexed citations
5.
6.
Barkai, Gad, Brian Reichman, Ehud Kokia, et al.. (1994). Fluorescence polarization of serum lipids in pregnancies complicated by hypertensive disorder. Journal of Perinatal Medicine. 22(2). 107–111. 2 indexed citations
7.
Meiner, Vardiella, Neville Berkman, Ayeleth Reshef, et al.. (1991). A common Lithuanian mutation causing familial hypercholesterolemia in Ashkenazi Jews.. Europe PMC (PubMed Central). 49(2). 443–9. 94 indexed citations
8.
Chambless, Lloyd E., Flávio Danni Fuchs, Shai Linn, et al.. (1990). The association of corneal arcus with coronary heart disease and cardiovascular disease mortality in the Lipid Research Clinics Mortality Follow-up Study.. American Journal of Public Health. 80(10). 1200–1204. 32 indexed citations
9.
Kokia, Ehud, Gad Barkai, Brian Reichman, et al.. (1990). Maternal serum lipid profile in pregnancies complicated by hypertensive disorders. Journal of Perinatal Medicine. 18(6). 473–478. 39 indexed citations
10.
Holtzman, Eliezer J., Talma Rosenthal, Uri Goldbourt, & P Segal. (1987). Do β-Blockers Alter Lipids and What Are the Consequences?. Journal of Cardiovascular Pharmacology. 10(Sup 2). S86–S93. 1 indexed citations
11.
Eisenberg, S, Gerardo Heiss, Yechiel Friedlander, et al.. (1986). Comparison of plasma lipids, lipoproteins and dyslipoproteinemia in Israel and the United States. Atherosclerosis. 59(1). 63–74. 7 indexed citations
12.
Holtzman, Eliezer J., Ginette Schiby, P Segal, & Israel E. Priel. (1986). Malignant fibrous histiocytoma complicating mitral valve replacement. Journal of the American College of Cardiology. 7(4). 956–960. 10 indexed citations
13.
Segal, P, William Insull, Lloyd E. Chambless, et al.. (1986). The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study.. PubMed. 73(1 Pt 2). I108–18. 35 indexed citations
14.
Hoeg, Jeffrey M., P Segal, Richard E. Gregg, et al.. (1985). Characterization of plasma lipids and lipoproteins in patients with β2-glycoprotein I (Apolipoprotein H) deficiency. Atherosclerosis. 55(1). 25–34. 24 indexed citations
15.
Holtzman, E, Talma Rosenthal, Uri Goldbourt, & P Segal. (1984). Different effects of metoprolol and chlorthalidone on serum lipoprotein levels in mild hypertension. Possible implications for coronary heart disease risk status.. PubMed. 20(12). 1169–76. 1 indexed citations
16.
Segal, P, et al.. (1983). The Prevalence of Diabetic Retinopathy: Effect of Sex, Age, Duration of Disease, and Mode of Therapy. Diabetes Care. 6(2). 149–151. 20 indexed citations
17.
Segal, P, Basil M. Rifkind, & William J. Schull. (1982). GENETIC FACTORS IN LIPOPROTEIN VARIATION. Epidemiologic Reviews. 4(1). 137–160. 25 indexed citations
18.
Inbar, Michael, Ralph F. Goldman, Isia Bursuker, et al.. (1977). Fluidity difference of membrane lipids in human normal and leukemic lymphocytes as controlled by serum components.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(9). 3037–41. 46 indexed citations
19.
Segal, P, Paul S. Roheim, & Howard A. Eder. (1972). Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats. Journal of Clinical Investigation. 51(7). 1632–1638. 42 indexed citations
20.
Segal, P, et al.. (1961). [Obstruction of the carotid artery from the ophthalmological viewpoint].. PubMed. 31. 117–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J D Morrisett Breakdown of academic impact, for papers by Masaharu Kubo Breakdown of academic impact, for papers by Hulda J. Wohltmann Breakdown of academic impact, for papers by J. Frohlich Breakdown of academic impact, for papers by A. Gustafson Breakdown of academic impact, for papers by Ryoyu Takeda Breakdown of academic impact, for papers by James P. Corsetti Breakdown of academic impact, for papers by Yuan-Teh Lee Breakdown of academic impact, for papers by Tomáš Štulc Breakdown of academic impact, for papers by M van Linde-Sibenius Trip
Rankless by CCL
2026